Overview of CHIC symposia series: Summary of Africa and South Asia symposia

In this overview, Bolio and colleagues summarize the key challenges and lessons learned from the CHIC Africa (Addis Ababa, 2022) and South Asia (New Delhi, 2022) symposia, involving participants from 19 African and 7 South Asian countries. Topics covered include health information systems, Gavi applications, planning, stakeholder engagement, delivery platforms, and single-dose vaccination. The article […]

HPV Vaccination Programs in LMICs from Asia & Western Pacific Regions Symposium – Report

This report summarizes the fourth CHIC symposium, held in Manila, Philippines (October 2–4, 2024), bringing together 95 participants from 17 countries across the Asia and Western Pacific regions. Participants included civil society organizations, Ministries of Health and Education, NGOs, NITAG members, EPI managers, and key global partners including WHO, UNICEF, Gavi, JSI, and PATH. The […]

Integrating HPV vaccine service delivery with adolescent health programmes – Experiences and perspectives from selected countries in Africa

In this case series, Ndiaye and colleagues describe how Senegal, Togo, Tanzania, and Lesotho have operationalized integrated HPV vaccine service delivery with adolescent health programmes. Across four countries, three models of integration emerge: incorporation into routine immunisation, co-delivery with non-vaccine adolescent health services (e.g., nutrition, deworming, sexual and reproductive health education), and leveraging new vaccine […]

Pandemic-related resilience in HPV vaccination programmes – Perspectives from selected countries in Africa on what it will take to vaccinate 90% of girls by 2030

In this series of five country case studies, Kouassi and colleagues document how Côte d’Ivoire, Kenya, Liberia, Zambia, and Senegal maintained and recovered their HPV vaccination programmes following COVID-19 disruptions. Common challenges included school closures, misinformation conflating HPV and COVID-19 vaccines, and competing health priorities that diverted staff and funding. Enabling factors included strong Ministry […]

Routine HPV vaccination: Reflection on delivery strategies based on countries’ experiences

In this commentary, Waheed and colleagues reflect on HPV vaccine delivery strategies across several low- and middle-income countries, comparing country experiences against existing WHO guidelines. Three delivery approaches are documented: routinized campaign-mode vaccination using schools as the primary site (The Gambia, Zambia, Ethiopia), routine health facility services complemented by community and school outreach (Tanzania, Kenya, […]

Mettre en lumière les défis: expériences nationales d’amélioration de la prestation de services face aux obstacles persistants – Questions-Réponses

Cette séance de questions-réponses a suivi les présentations de la Gambie, du Sénégal et du Zimbabwe sur les défis de la prestation de services HPV, avec des interventions complémentaires du Kenya et du Rwanda. La Gambie a précisé que la rupture de stock de 2024 résultait d’une baisse de la demande post-COVID ayant entraîné la […]

Mettre en lumière les défis: expériences nationales d’amélioration de la prestation de services face aux obstacles persistants – Zimbabwe

Au Zimbabwe, la vaccination en milieu scolaire constitue le principal modèle de prestation depuis le déploiement national en 2018, complétée par des stratégies de proximité communautaire et des sites de santé fixes, ciblant les filles de CM1 et les filles non scolarisées de 10 ans. Le programme bénéficie d’une coordination interministérielle solide entre le Ministère […]

Mettre en lumière les défis: expériences nationales d’amélioration de la prestation de services face aux obstacles persistants – Gambie

En Gambie, le Programme Élargi de Vaccination gère 486 points de prestation vaccinale mensuels combinant sites fixes et stratégies avancées, avec la vaccination en milieu scolaire et les activités trimestrielles de PIRI comme modalités principales. Suite à une recommandation du NITAC, le pays est passé à un schéma à dose unique en janvier 2025, ce […]

>